Routine Analysis of IgVHMutational Status in CLL Patients using BIOMED-2 Standardized Primers and Protocols
- 1 September 2004
- journal article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 45 (9), 1899-1904
- https://doi.org/10.1080/10428190410001710812
Abstract
Current methods for the detection of IgVH mutational status in chronic lymphocytic leukemia (CLL), which identifies 2 subgroups of patients with significantly different outcomes, are laborious, expensive and do not lend themselves to a routine diagnostic setting. With the introduction of BIOMED-2 primers, a rapid protocol is now available. This study evaluated the protocol by examining DNA from 100 CLL patients. Conventional methods using RNA, and fluorescence in-situ hybridization (FISH) analysis for recurring chromosomal abnormalities, were carried out on 30 and 60 of these patients, respectively. There was complete concordance between the BIOMED-2 protocol and the RNA based method, both in mutational status and gene usage, whilst unmutated IgVH genes showed association with 17p13 and 11q23 deletions, and trisomy 12, associated with poor and intermediate outcomes, respectively. This study demonstrates that it is feasible to use the BIOMED-2 protocol in the diagnostic profile of CLL patients, obviating the need for inclusion of surrogate markers such as ZAP-70.Keywords
This publication has 11 references indexed in Scilit:
- Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2003
- Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vλ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeBlood, 2003
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaBlood, 2002
- Chronic lymphocytic leukemiaCurrent Opinion in Hematology, 2000
- Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic LeukemiaBlood, 1999
- Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic LeukemiaBlood, 1999
- B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different FeatherJournal of Clinical Oncology, 1999
- The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacementImmunology Today, 1994